More Dipna Pharmachem Limited news Dipna Pharmachem LimitedBSE: DPL Outcome And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Oct 24, 2026 at 7:25 AM EDT · Issued by Dipna Pharmachem Limited via BSE India Filed with BSE · Oct 24, 2026 at 7:25 AM EDTOn 6ix: 6ix.com/news/outcome-and-intimation-under-regulation-30-of-the-sebi-listing-obligations-and-disclosure-requirements-regulations-2015-1Dipna PharmachemView Attachment6ix is reading this filing. View original source (BSE India)Dipna Pharmachem Limited on 6ix Story so farAnnouncement under Regulation 30 (LODR)-Resignation of DirectorOct 24, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateOct 24, 2026Board Meeting Outcome for Outcome And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Oct 24, 2026 Earlier from Dipna PharmachemAnnouncement under Regulation 30 (LODR)-Resignation of DirectorOct 24Announcement under Regulation 30 (LODR)-Change in DirectorateOct 24Dipna Pharmachem Limited Press Release Sep 30 2026Sep 30Closure of Trading WindowSep 30Dipna Pharmachem Limited Press Release Jul 01 2026Jul 1All Dipna Pharmachem news releases↗Follow Dipna Pharmachem into a list and get an email when it puts out news.Follow Dipna Pharmachem